Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines.
- Resource Type
- Article
- Source
- NPJ Vaccines; 2/14/2020, Vol. 5 Issue 1, p1-6, 6p
- Subject
PAPILLOMAVIRUSES HUMAN papillomavirus vaccines IMMUNOGLOBULINS HIV-positive persons SEROPREVALENCE - Language
- ISSN
- 20590105